IP Library Granted Patent US 7,514,434
Granted Patent B2
US 7,514,434 · App. 11/063,255 · Granted Apr 7, 2009

Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,514,434
App. No.
11/063,255
Granted
Apr 7, 2009
Kind
B2
Abstract

The present invention relates to substituted diphenyl heterocycle compounds having an oxadiazole moiety and pharmaceutical compositions thereof that inhibit replication of HCV virus. The present invention also relates to the use of the compounds and/or compositions to inhibit HCV replication and/or proliferation and to treat or prevent HCV infections.

Claims (229)

1. A compound according to the structural formula,

or a pharmaceutically acceptable salt, N-oxide, or prodrug thereof, wherein:

each X, independently, is a leaving group;

R 2 , R 3 , R 4 , R 5 , R 6 , R 8 , R 9 , R 10 and R 13 are each, independently of one another, selected from the group consisting of hydrogen, —OH, —SH, —CN, —NO 2 , —N 3 , halo, fluoro, chloro, bromo, iodo, lower alkyl, substituted lower alkyl, lower heteroalkyl, substituted lower heteroalkyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, lower haloalkyl, monohalomethyl, dihalomethyl, trihalomethyl, trifluoromethyl, lower alkylthio, substituted lower alkylthio, lower alkoxy, substituted lower alkoxy, methoxy, substituted methoxy, lower heteroalkoxy, substituted lower heteroalkoxy, cycloalkoxy, substituted cycloalkoxy, cycloheteroalkoxy, substituted cycloheteroalkoxy, lower haloalkoxy, monohalomethoxy, dihalomethoxy, trihalomethoxy, trifluoromethoxy, amino, lower di- or monoalkylamino, substituted lower di- or monoalkylamino, aryl, substituted aryl, aryloxy, substituted aryloxy, phenoxy, substituted phenoxy, arylalkyl, substituted arylalkyl, arylalkyloxy, substituted arylalkyloxy, benzyl, benzyloxy, heteroaryl, substituted heteroaryl, heteroaryloxy, substituted heteroaryloxy, heteroarylalkyl, substituted heteroarylalkyl, heteroarylalkyloxy, substituted heteroarylalkyloxy, carboxyl, lower alkoxycarbonyl, substituted lower alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, arylalkyloxycarbonyl, substituted arylalkyloxycarbonyl, carbamate, substituted carbamate, carbamoyl, substituted carbamoyl, sulfamoyl, substituted sulfamoyl and a group of the formula -L-R 14 , where “L” is a linker and R 14 is cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl; and

R 16 and R 18 are each, independently of one another, selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, lower heteroalkyl, substituted lower heteroalkyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, lower haloalkyl, monohalomethyl, dihalomethyl, trihalomethyl, trifluoromethyl, lower alkylthio, substituted lower alkylthio, lower alkoxy, substituted lower alkoxy, methoxy, substituted methoxy, lower heteroalkoxy, substituted lower heteroalkoxy, cycloalkoxy, substituted cycloalkoxy, cycloheteroalkoxy, substituted cycloheteroalkoxy, lower haloalkoxy, monohalomethoxy, dihalomethoxy, trihalomethoxy, trifluoromethoxy, lower di- or monoalkylamino, substituted lower di- or monoalkylamino, aryl, substituted aryl, aryloxy, substituted aryloxy, phenoxy, substituted phenoxy, arylalkyl, substituted arylalkyl, arylalkyloxy, substituted arylalkyloxy, benzyl, benzyloxy, heteroaryl, substituted heteroaryl, heteroaryloxy, substituted heteroaryloxy, heteroarylalkyl, substituted heteroarylalkyl, heteroarylalkyloxy, substituted heteroarylalkyloxy, carboxyl, lower alkoxycarbonyl, substituted lower alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, arylalkyloxycarbonyl, substituted arylalkyloxycarbonyl, carbamate, substituted carbamate, carbamoyl, substituted carbamoyl, sulfamoyl, substituted sulfamoyl and a group of the formula -L-R 14 , where “L” is a linker and R 14 is cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl.

2. The compound of claim 1 in which R 8 , R 9 , R 10 and R 13 are each hydrogen.

3. The compound of claim 1 in which R 3 and R 5 are each hydrogen.

4. The compound of claim 3 in which R 4 is -L-R 14 .

5. The compound of claim 4 in which L is —O—(CH 2 ) 1-3 — and R 14 is N-morpholinyl.

6. The compound of claim 1 in which R 3 , R 4 and R 5 are each hydrogen.

7. The compound of claim 6 in which R 2 and R 6 are each, independently of one another, selected from the group consisting of —OH, —NO 2 , halo, fluoro, chloro, bromo, iodo, lower alkyl, methyl, lower heteroalkyl, (C3-C6) cycloalkyl, 5- or 6-membered cycloheteroalkyl, N-morpholinyl, N-methyl-N-piperazinyl, N-piperidinyl, substituted N-piperidinyl, 4-(N-piperidinyl)-N-piperidinyl, 4-amino-N-piperidinyl, lower alkoxy, methoxy, ethoxy, lower alkylthio, methylthio, lower haloalkyl, monohalomethyl, dihalomethyl, trihalomethyl, trifluoromethyl, lower haloalkyloxy, monohalomethoxy, dihalomethoxy, trihalomethoxy, trifluoromethoxy, aryl, phenyl, arylalkyl, benzyl, aryloxy, phenoxy, arylalkyloxy, benzyloxy, 5- or 6-membered heteroaryl, lower alkyloxycarbonyl, sulfamoyl and -L-R 14 , where L is —(CH 2 ) 1-3 — or —O—(CH 2 ) 1-3 — and R 14 is a 5- or 6-membered cycloheteroalkyl or N-morpholinyl.

8. The compound of claim 1 in which R 2 is Cl or CF 3 , R 3 is H, R 4 is H, R 5 is H,

R 6 is

 OCH 3 , or Cl,

R 8 is H or F, R 9 is H, R 10 is H, and R 13 is H.

9. A compound according to the structural formula,

or a pharmaceutically acceptable salt, hydrate, solvate, N-oxide, or prodrug thereof, wherein:

each X, independently, is a leaving group;

R 2 , R 3 , R 4 , R 5 , R 6 , R 8 , R 9 , R 10 and R 13 are each, independently of one another, selected from the group consisting of hydrogen, —OH, —SH, —CN, —NO 2 , —N 3 , halo, fluoro, chloro, bromo, iodo, lower alkyl, substituted lower alkyl, lower heteroalkyl, substituted lower heteroalkyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, lower haloalkyl, monohalomethyl, dihalomethyl, trihalomethyl, trifluoromethyl, lower alkylthio, substituted lower alkylthio, lower alkoxy, substituted lower alkoxy, methoxy, substituted methoxy, lower heteroalkoxy, substituted lower heteroalkoxy, cycloalkoxy, substituted cycloalkoxy, cycloheteroalkoxy, substituted cycloheteroalkoxy, lower haloalkoxy, monohalomethoxy, dihalomethoxy, trihalomethoxy, trifluoromethoxy, amino, lower di- or monoalkylamino, substituted lower di- or monoalkylamino, aryl, substituted aryl, aryloxy, substituted aryloxy, phenoxy, substituted phenoxy, arylalkyl, substituted arylalkyl, arylalkyloxy, substituted arylalkyloxy, benzyl, benzyloxy, heteroaryl, substituted heteroaryl, heteroaryloxy, substituted heteroaryloxy, heteroarylalkyl, substituted heteroarylalkyl, heteroarylalkyloxy, substituted heteroarylalkyloxy, carboxyl, lower alkoxycarbonyl, substituted lower alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, arylalkyloxycarbonyl, substituted arylalkyloxycarbonyl, carbamate, substituted carbamate, carbamoyl, substituted carbamoyl, sulfamoyl, substituted sulfamoyl and a group of the formula -L-R 14 , where “L” is a linker and R 14 is cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl,

provided that at least one of R 2 or R 6 is other than hydrogen; and

R 16 and R 18 are each, independently of one another, selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, lower heteroalkyl, substituted lower heteroalkyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, lower haloalkyl, monohalomethyl, dihalomethyl, trihalomethyl, trifluoromethyl, lower alkylthio, substituted lower alkylthio, lower alkoxy, substituted lower alkoxy, methoxy, substituted methoxy, lower heteroalkoxy, substituted lower heteroalkoxy, cycloalkoxy, substituted cycloalkoxy, cycloheteroalkoxy, substituted cycloheteroalkoxy, lower haloalkoxy, monohalomethoxy, dihalomethoxy, trihalomethoxy, trifluoromethoxy, lower di- or monoalkylamino, substituted lower di- or monoalkylamino, aryl, substituted aryl, aryloxy, substituted aryloxy, phenoxy, substituted phenoxy, arylalkyl, substituted arylalkyl, arylalkyloxy, substituted arylalkyloxy, benzyl, benzyloxy, heteroaryl, substituted heteroaryl, heteroaryloxy, substituted heteroaryloxy, heteroarylalkyl, substituted heteroarylalkyl, heteroarylalkyloxy, substituted heteroarylalkyloxy, carboxyl, lower alkoxycarbonyl, substituted lower alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, arylalkyloxycarbonyl, substituted arylalkyloxycarbonyl, carbamate, substituted carbamate, carbamoyl, substituted carbamoyl, sulfamoyl, substituted sulfamoyl and a group of the formula -L-R 14 , where “L” is a linker and R 14 is cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl.

10. The compound of claim 9 in which R 2 is Cl or CF 3 , R 3 is H, R 4 is H, R 5 is H,

R 6 is Cl, F,

 or OCH 3 ,

R 8 is H, Cl, or F, R 9 is H, R 10 is H or CH 3 , and R 13 is H.

11. The compound of claim 1 which is:

R 2

R 3

R 4

R 5

R 6

R 8

R 9

R 10

R 13

X's

Cl

H

H

H

H

H

H

H

Cl

Cl

H

H

H

H

H

H

H

Cl

Cl

H

H

H

H

H

H

H

Cl

CF 3

H

H

H

OMe

H

H

H

H

Cl

Cl

H

H

H

Cl

H

H

H

H

Cl

Cl

H

H

H

Cl

F

H

H

H

Cl.

12. The compound of claim 9 which is:

R 2

R 3

R 4

R 5

R 6

R 8

R 9

R 10

R 13

X's

Cl

H

H

H

Cl

H

H

H

H

Cl

R 2

R 3

R 4

R 5

R 6

R 8

R 9

R 10

R 13

X's

Cl

H

H

H

Cl

H

H

H

Cl

Cl

H

H

H

Cl

H

H

Me

H

Cl

Cl

H

H

H

F

H

H

H

Cl

Cl

H

H

H

H

H

H

H

Cl

Cl

H

H

H

H

H

H

H

Cl

Cl

H

H

H

H

H

H

H

Cl

CF 3

H

H

H

F

H

H

H

H

Cl

Cl

H

H

H

F

H

H

H

H

Cl

CF 3

H

H

H

OMe

H

H

H

H

Cl

Cl

H

H

H

Cl

H

H

H

H

Cl

Cl

H

H

H

Cl

Cl

H

H

H

Cl.

Assignments (3)
SECURITY INTEREST Recorded May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2005
From: GOFF, DANE; SINGH, RAJINDER; LU, HENRY
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 016584/0286 →